RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $129
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Deane Dray has maintained an 'Outperform' rating on Xylem (NYSE:XYL), but lowered the price target from $133 to $129.

August 04, 2023 | 1:39 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RBC Capital has maintained an 'Outperform' rating on Xylem, but lowered the price target from $133 to $129. This could potentially impact the stock's performance.
The 'Outperform' rating suggests that RBC Capital expects Xylem to do better than the market average. However, the lowering of the price target could indicate a slightly less optimistic outlook than before, which might affect investor sentiment and the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100